Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
CRON | US
-0.05
-1.95%
Healthcare
Biotechnology
30/06/2024
09/03/2026
2.52
2.54
2.54
2.46
Cronos Group Inc. operates as a cannabinoid company. It manufactures markets and distributes hemp-derived supplements and cosmetic products through e-commerce retail and hospitality partner channels under the Lord Jones brand in the United States. The company is also involved in the cultivation manufacture and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products including dried cannabis pre-rolls edibles concentrates and cannabis extracts through wholesale and direct-to-client channels under its wellness platform PEACE NATURALS; and operates under adult-use brands Spinach. Cronos Group Inc. was founded in 2012 and is based in Toronto Canada.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
32.2%1 month
28.2%3 months
49.9%6 months
47.2%-
-
0.79
0.00
0.00
-1.42
0.02
-
-61.51M
967.28M
967.28M
-
-54.08
14.40
46.00
-5.29
5.63
2.49
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.32
Range1M
0.32
Range3M
1.03
Rel. volume
1.42
Price X volume
4.16M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Vor Biopharma Inc | VOR | Biotechnology | 15.46 | 1.06B | 2.25% | n/a | 34.48% |
| Inhibrx Inc. | INBX | Biotechnology | 71.86 | 1.04B | 3.87% | 0.13 | 0.99% |
| Biohaven Pharmaceutical Holding Company Ltd | BHVN | Biotechnology | 10.21 | 1.03B | 2.92% | n/a | 7.75% |
| Progenitor Inc | PGEN | Biotechnology | 3.51 | 1.03B | 5.72% | n/a | 14.69% |
| Recursion Pharmaceuticals Inc. Class A Common Stock | RXRX | Biotechnology | 3.51 | 1.02B | 1.45% | n/a | 15.38% |
| Array BioPharma Inc | ARRY | Biotechnology | 6.73 | 1.02B | -1.17% | 68.10 | 117.68% |
| Corvus Pharmaceuticals Inc | CRVS | Biotechnology | 15.89 | 993.94M | 0.60% | n/a | 1.37% |
| AbCellera Biologics Inc | ABCL | Biotechnology | 3.52 | 990.74M | 2.03% | n/a | 6.49% |
| Geron Corporation | GERN | Biotechnology | 1.62 | 976.53M | 5.88% | n/a | 28.38% |
| Taysha Gene Therapies Inc | TSHA | Biotechnology | 4.59 | 940.69M | 0.44% | n/a | 53.02% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Winnebago Industries Inc | WGO | Recreational Vehicles | 35.25 | 1.02B | -2.87% | 22.53 | 56.33% |
| Janus International Group Inc. | JBI | Building Products & Equipment | 5.39 | 783.29M | 1.89% | 11.62 | 116.21% |
| Latham Group Inc. | SWIM | Building Products & Equipment | 6.31 | 729.29M | 0.16% | 65.18 | 77.00% |
| Fox Factory Holding Corp | FOXF | Recreational Vehicles | 16.37 | 682.35M | 0.37% | 42.05 | 64.69% |
| Ennis Inc | EBF | Building Products & Equipment | 21.16 | 550.24M | -0.70% | 13.28 | 2.28% |
| Malibu Boats Inc | MBUU | Recreational Vehicles | 25.67 | 513.16M | -0.39% | n/a | 1.50% |
| ACCO Brands Corporation | ACCO | Building Products & Equipment | 3.67 | 351.58M | -6.14% | n/a | 174.23% |
| Camping World Holdings Inc | CWH | Recreational Vehicles | 7.47 | 337.11M | 1.49% | n/a | 3644.76% |
| MCBC Holdings Inc | MCFT | Recreational Vehicles | 19.38 | 321.85M | -1.77% | 34.27 | 26.82% |
| Marine Products Corporation | MPX | Recreational Vehicles | 7.01 | 243.37M | -1.13% | 13.23 | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -1.42 | 0.53 | Cheaper |
| Ent. to Revenue | 0.02 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 0.79 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 49.93 | 72.80 | Lower Risk |
| Debt to Equity | 0.00 | -1.23 | Expensive |
| Debt to Assets | 0.00 | 0.25 | Cheaper |
| Market Cap | 967.28M | 3.66B | Emerging |